Skip to main content

Table 1 Baseline clinical, echocardiographic, and laboratory data of the study population

From: Response of circulating heat shock protein 70 and anti-heat shock protein 70 antibodies to catheter ablation of atrial fibrillation

 

AF population

Controls

 

n=67

n=34

Age (years)

59 ± 11

59 ± 11

Males (%)

66

66

Paroxysmal AF (%)

58

0

Lone AF (%)

66

-

AF history (months)

72 ± 60

-

LVEF (%)

60 ± 9

62 ± 8

LAD (mm)

43 ± 6

41 ± 5

anti-HSP70 antibodies (μg/ml)

48 [36 – 72]

40 [32 – 70]

HSP70 (ng/ml)*

0 [0 – 0]

0 [0 – 0]

hs-CRP (μg/ml)

2.07 ± 1.10

1.80 ± 0.85

  1. HSP70 and anti-HSP70 antibodies are presented as median [IQR].
  2. * detectable in 21% of AF patients and 19% of controls.
  3. LAD = left atrial diameter, LVEF = left ventricular ejection fraction.
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us